170 related articles for article (PubMed ID: 3519413)
21. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
22. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
Gérard J; Luyckx AS; Lefebvre PJ
Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
[TBL] [Abstract][Full Text] [Related]
23. Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
Clissold SP; Edwards C
Drugs; 1988 Mar; 35(3):214-43. PubMed ID: 3286212
[TBL] [Abstract][Full Text] [Related]
24. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
Walton RJ; Sherif IT; Noy GA; Alberti KG
Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
[TBL] [Abstract][Full Text] [Related]
25. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
[No Abstract] [Full Text] [Related]
26. Acarbose and insulin therapy in type I diabetes mellitus.
Rios MS
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():36-9. PubMed ID: 8001626
[TBL] [Abstract][Full Text] [Related]
27. Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion.
Dash S; Crisp S; Hartnell S; Donald S; Davenport K; Simmons D; Evans M
Diabetes Res Clin Pract; 2012 Mar; 95(3):e49-51. PubMed ID: 22136721
[TBL] [Abstract][Full Text] [Related]
28. Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the alpha-glucosidase inhibitor acarbose.
Frantz S; Calvillo L; Tillmanns J; Elbing I; Dienesch C; Bischoff H; Ertl G; Bauersachs J
FASEB J; 2005 Apr; 19(6):591-3. PubMed ID: 15671153
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of CuSO₄ on α-glucosidase activity in ddY mice.
Yoshikawa Y; Hirata R; Yasui H; Hattori M; Sakurai H
Metallomics; 2010 Jan; 2(1):67-73. PubMed ID: 21072376
[TBL] [Abstract][Full Text] [Related]
30. Effect of long-term treatment with insulin and/or acarbose on glomerular basement membrane thickening in alloxan-diabetic rats.
Macedo CS; Silva MD; Spadella CT; Breim LC; Capeletti S; Mercadante MC; Hernandes D; Macedo AR
Braz J Med Biol Res; 1996 Oct; 29(10):1329-35. PubMed ID: 9181105
[TBL] [Abstract][Full Text] [Related]
31. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio F; Compagnucci P
Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
[TBL] [Abstract][Full Text] [Related]
32. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
Madar Z
J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
[TBL] [Abstract][Full Text] [Related]
33. Insulin binding and glucose transport in adipocytes of acarbose-treated Zucker lean and obese rats.
Vasselli JR; Flory T; Fried SK
Int J Obes; 1987; 11 Suppl 3():71-5. PubMed ID: 3326849
[TBL] [Abstract][Full Text] [Related]
34. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes.
Buchanan DR; Collier A; Rodrigues E; Millar AM; Gray RS; Clarke BF
Eur J Clin Pharmacol; 1988; 34(1):51-3. PubMed ID: 3282895
[TBL] [Abstract][Full Text] [Related]
36. alpha-Glucosidase inhibition in obesity.
William-Olsson T
Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
[TBL] [Abstract][Full Text] [Related]
37. The acute effects of glucosidase inhibition on post-meal glucose increments in insulin-dependent diabetics.
Wing J; Kalk WJ; Berzin M; Diamond TH; Griffiths RF; Smit AM; Osler CE
S Afr Med J; 1990 Mar; 77(6):286-8. PubMed ID: 2180090
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of alpha-glucosidase inhibition.
Bischoff H
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of sugars and the alpha-glucosidase inhibitor acarbose (Bay g 5421) on satiety in the Zucker obese rat.
Maggio CA; Decarr LB; Vasselli JR
Int J Obes; 1987; 11 Suppl 3():53-6. PubMed ID: 3326848
[TBL] [Abstract][Full Text] [Related]
40. Double-blind crossover study of acarbose in type 1 diabetic patients.
Marena S; Tagliaferro V; Cavallero G; Pagani A; Montegrosso G; Bianchi W; Zaccarini P; Pagano G
Diabet Med; 1991; 8(7):674-8. PubMed ID: 1833121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
